The World Health Organization has formally requested additional details from Russian authorities following the death of an employee at a plague research facility in Siberia. The circumstances surrounding how the worker became infected remain under investigation, and the lack of a definitive explanation has fuelled widespread speculation in the media. Russian officials have said they are still working to determine the cause of death, but they have confirmed that everyone who had contact with the researcher tested negative for pneumonic plague.
Pneumonic plague is widely regarded as the most severe and virulent manifestation of plague, a disease that has haunted human history for centuries. Unlike the bubonic form, which attacks the lymph nodes, or the septicaemic form, which affects the blood, pneumonic plague is a serious lung infection. It can also emerge as a complication after a patient first develops one of the other two types, with the infection then spreading into the lungs.
The symptoms of pneumonic plague are alarming and progress rapidly. Patients typically experience shortness of breath and chest pain, and they frequently cough up blood. Because the infection targets the respiratory system so aggressively, it is considered more dangerous than bubonic plague, although it is also less common. The short incubation period — sometimes as little as 24 hours, according to the World Health Organization — means that timely diagnosis and treatment are critical.
Globally, the number of plague infections of all three types fluctuates from year to year, but estimates suggest there are somewhere between 1,000 and 3,000 cases annually. The majority of these are bubonic plague, and many occur in central Africa. However, cases also appear in other parts of the world, including Russia, India, China, and the United States, demonstrating that the disease is not confined to any single region.
Prof Piero Olliaro, Professor of Poverty-Related Infectious Diseases at the University of Oxford, emphasised that plague has never truly disappeared. He explained that the bacterium responsible, Yersinia pestis, persists in animal reservoirs across many parts of the world. Around 200 rodent species can harbour the bacterium, with reservoirs found throughout the Americas, Eurasia, and Africa. As a result, sporadic human cases continue to occur. However, Olliaro noted that established surveillance, infection-control measures, and effective antibiotic treatment are important tools for limiting the impact of the disease.
Understanding how plague spreads is essential to controlling it. The disease is caused by bacteria usually found in small mammals and their fleas. Humans can become infected through the bite of an infected flea or by handling an infected animal. In the case of pneumonic plague, however, human-to-human transmission is also possible. This occurs when an infected person coughs droplets into the air, which are then inhaled by another person. Such transmission normally requires quite close contact between individuals.
There is also an indirect pathway to developing pneumonic plague. A person who has had septicaemic plague may see the infection spread into the lungs, at which point the disease takes on the pneumonic form. This adds another layer of complexity to how the disease can present and spread within a population.
Historically, pneumonic plague is believed to have been the primary type behind the Black Death, the catastrophic outbreak that killed millions of people across Europe in the 14th Century. That devastating episode cemented plague's reputation as one of the most feared infectious diseases in human history. Yet experts stress that plague is not merely a historical curiosity — it remains a present-day public health concern.
Dr Zania Stamataki, Associate Professor of Viral Immunology at the University of Birmingham, acknowledged that the idea of plague being studied in a laboratory can sound alarming to the public. She said it is worth explaining why such work exists. According to Stamataki, plague is not a historical disease — it remains endemic in rodent populations across Africa, Asia, and the Americas, and human cases occur every year, including outbreaks of the pneumonic form. She noted that diagnostics, vaccine development, and surveillance for antibiotic resistance all require laboratories that hold and study the live organism, and that this work is vital to prepare against outbreaks.
The good news, experts say, is that plague responds well to antibiotics when treatment begins early. Without prompt diagnosis and treatment, however, pneumonic plague is nearly always fatal. Dr Malick Gibani, Clinical Associate Professor in Bacterial Vaccinology at Imperial College London, described pneumonic plague as a very severe manifestation of plague disease. He noted that some textbooks state it has a 100% mortality rate if left untreated, though accurate modern figures are difficult to establish. Gibani stressed that it is treatable with antibiotics, particularly if started early, which is why anyone with high-risk potential exposure might be offered post-exposure prophylaxis with antibiotics and/or quarantine.
In the Russian case, it is still not clear whether the individual who died was actually infected by pneumonic plague. Russian authorities have issued a statement saying that tests showed "no microorganisms associated with the patient's professional activities." At this stage, therefore, the exact sequence of events remains uncertain. The lack of clarity has not prevented the case from drawing international attention.
US President Donald Trump said Washington was looking "very strongly" at the case, while the Centers for Disease Control (CDC) stated there was "no indication of a broader threat to the United States." The UK's Health and Safety Authority said it was seeking more information, but assessed that the risk to Britain's population was "very low." These reassurances reflect the broader view among health agencies that the incident, while serious, does not currently signal a wider public health emergency.
The episode serves as a reminder that plague, though rare and treatable, has not been eradicated. Its persistence in animal reservoirs around the world means that sporadic human cases will continue to emerge. For health authorities, the priorities remain swift diagnosis, early antibiotic treatment, and robust surveillance systems capable of detecting and containing outbreaks before they spread. As the investigation in Siberia continues, the case underscores the importance of the very laboratories that study this ancient pathogen — facilities that many find unsettling, but which experts argue are indispensable to global preparedness.
(0)